D Tian, Y Liu, C Liang, L Xin, X Xie, D Zhang… - Biomedicine & …, 2021 - Elsevier
… The 2019 coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, 90 million people have been infected …
Y Zhu, J Li, Z Pang - Asian Journal of Pharmaceutical Sciences, 2021 - Elsevier
… out effective vaccines for the prevention of COVID-19. Herein, the present review will … therapeuticoptions for COVID-19 as well as some insightful discussions of the status of COVID-19…
MA Ullah, Y Araf, B Sarkar, AT Moin, RAI Reshad… - 2020 - preprints.org
… Monoclonal antibodies (mAbs) provide excellent therapeuticoption to prevent the SARS-CoV … be potential therapeuticoption for COVID-19 treatment [118]. F26G18 and F26G19 are two …
… With the number of Coronavirus Disease 2019 (COVID-19) … a viable therapeuticoption to treat COVID-19 disease and its … antibodies used to treat COVID-19, with special attention paid …
C Li, BH Xu - European Review for Medical & Pharmacological …, 2020 - europeanreview.org
… Recently, WHO has defined COVID-19 as a global pandemic… COVID-19, in order to provide recommendations for present clinical treatments and inspirations for potential therapyoptions…
… led to the mortality in COVID-19 patients. The therapeuticoptions that may act as a potential treatment for the inflammatory conditions associated with COVID-19 are also discussed. …
JM Mir, RC Maurya - New Journal of Chemistry, 2021 - pubs.rsc.org
… This work aims to describe the therapeutic potential of NO for the treatment of deadly COVID-19. The … are supportive of the fact to declare NO as a therapeuticoption for this disease. …
V Singh, V Mishra - Coronaviruses, 2021 - ingentaconnect.com
… against COVID-19 and some promising results have been achieved. This review focuses on several therapeuticoptions for COVID-19, such as anti-viral drugs, vaccines, plasma therapy…
M Sisay - Frontiers in pharmacology, 2020 - frontiersin.org
… remdesivir as a potential therapeuticoption for COVID-19. … be a potential therapeuticoption for the therapy of COVID-19 … was started on day 7 in COVID-19 patient. During the treatemnt…